Antiarrhythmic drug approval--an industry perspective.
Jacobs
S
S
Cardiovascular Products, Bristol-Myers Squibb Pharmaceutical Group, Montreal, Quebec.
D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004341:Drug Evaluation / Q000592:standards*; D004345:Drug Industry; D006801:Humans; D007880:Legislation, Drug; D014481:United States; D014486:United States Food and Drug Administration
D000889:Anti-Arrhythmia Agents